Computational Pathology
Overview
Computational pathology studies how to extract diagnostic and biological information from digitized tissue and cell images, including whole-slide images, biopsies, and cytology. Common approaches include convolutional and vision-transformer models, weakly supervised multiple-instance learning for slide-level labels, and segmentation or graph methods for cells and tissue structure; benchmarks such as CAMELYON and PANDA test detection and grading. Foundation and vision-language models increasingly align image features with reports, clinical records, and molecular data for retrieval, prognosis, virtual staining, and spatial gene-expression prediction. A central challenge is ensuring that models remain reliable across hospitals, scanners, and stains while producing interpretable evidence and demonstrating benefit in prospective clinical workflows.
Latest papers
280 papers33 papers in the last four weeks, up 18% on the four weeks before. 0.2% of all new papers.
Understanding Synergistic Interactions among Pathology Foundation Models via Adaptive Fusion
Harnessing Adversarial Distillation to Customise Debiased, Disease-Specific Pathology Foundation Models for Breast Cancer
Zero-Cost Virtual RNA: Approximating Immunotherapy Signatures via Cross-Modal WSI Retrieval
Inflamed'' immunophenotype in Gastric Adenocarcinoma predicts immunotherapy response but requires an expensive 10-gene RNA signature. While deep learning on standard H\&E slides offers a scalable alternative, conventional binary classifiers oversimplify continuous RNA data and introduce label noise. To resolve this, we propose VITA (VIrtual Transcriptomic Approximation). By aligning H\&E and RNA into a joint latent space during training, VITA requires only standard H\&E at inference to retrieve morphologically similar historical cases and approximate the continuous RNA signature. Achieving 0.72 classification accuracy and a 0.66 Spearman correlation, VITA provides a cost-effective virtual transcriptomics'' pre-screening tool that preserves the continuous phenotypic spectrum without requiring genomic sequencing.